spacer
The Healthcare Sales & Marketing Network celebrates 23 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Healthcare Industry NewsFeed

 HSMN NewsFeed - 27 Jan 2021
Ukko Secures $40 Million in Series B Funding Led by Leaps by Bayer to Overcome Food Allergies and Sensitivities
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Jan 2021
Nuvalent Launches with $50M Series A Financing from Deerfield Management to Develop Precisely Targeted Kinase Inhibitors for Treatment-Resistant Cancers
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 27 Jan 2021
Smith & Nephew's PICO(TM) Single Use Negative Pressure Wound Therapy System again shown to significantly reduce surgical site complications
Devices Surgery Wound Care
 HSMN NewsFeed - 26 Jan 2021
Scott Huennekens joins 270Surgical Board of Directors, Observer and Advisor
Devices Surgery Personnel
 HSMN NewsFeed - 26 Jan 2021
Connect Biopharma Strengthens Leadership Team with Key Hire
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jan 2021
BD Names CEO Tom Polen as Chairman of the Board
Devices Personnel
 HSMN NewsFeed - 26 Jan 2021
The Henry Ford Cancer Institute Installs its Second ViewRay MRIdian(R) Linac
Devices Oncology
 HSMN NewsFeed - 25 Jan 2021
PEDRA(TM) Technology Receives FDA Breakthrough Device Designation for its PEDRA(TM) Xauron(TM) Real-Time Tissue Perfusion System
Devices Monitoring FDA
 HSMN NewsFeed - 25 Jan 2021
Candela announces the launch of the Frax Pro(TM) system, the smart way to Frax
Devices Dermatology Product Launch
 HSMN NewsFeed - 25 Jan 2021
FDA Approves Theranica's Nerivio(R) for Acute Treatment of Migraine in Adolescents
Devices Neurology FDA
 HSMN NewsFeed - 25 Jan 2021
OrthoSpin Ltd. Receives FDA Regulatory Clearance for its G2 System
Devices Orthopaedic FDA
 HSMN NewsFeed - 25 Jan 2021
Eiger BioPharmaceuticals Announces U.S. Commercial Availability of Zokinvy(TM) (lonafarnib), the First and Only Treatment Approved for Progeria and Processing-Deficient Progeroid Laminopathies
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 22 Jan 2021
Lilly Completes Acquisition of Prevail Therapeutics
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 22 Jan 2021
Boston Scientific Receives FDA Approval For The Vercise Genus(TM) Deep Brain Stimulation System
Devices Neurology FDA
 HSMN NewsFeed - 21 Jan 2021
BiondVax Announces Appointment of Amir Reichman as New CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jan 2021
Boston Scientific Announces Agreement To Acquire Preventice Solutions, Inc.
Devices Monitoring Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 21 Jan 2021
MIVI Neuroscience Secures Series B Funding
Devices Interventional Neurology Venture Capital
More stories   Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.